MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • White Papers
  • DeviceTalks

Surmodics posts Street-beating FY2019 Q1 earnings

January 30, 2019 By Fink Densford Leave a Comment

Surmodics (NSDQ:SRDX) today posted fiscal year 2019 first quarter earnings that beat expectations on Wall Street. The Eden Prairie, Minn.-based company posted profits of $1.3 million, or 9¢ per share, on sales of approximately $22.2 million for the three months ended December 31, seeing a swing from the red on the bottom line while sales grew […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: SurModics Inc.

Surmodics tops Q4 sales estimates, misses on EPS

November 9, 2018 By Sarah Faulkner Leave a Comment

Shares in Surmodics (NSDQ:SRDX) fell today after the medical device maker topped sales expectations but missed EPS estimates on Wall Street with its fourth-quarter financial results. The Eden Prairie, Minn.-based company was in the red this quarter, posting a net loss of -$1.8 million, or -13¢ per share, on sales of $23 million for the three months ended […]

Filed Under: Drug-Device Combinations, MassDevice Earnings Roundup, Vascular, Wall Street Beat Tagged With: SurModics Inc.

VIVA 2018 Roundup: Surmodics reports positive one-year data for SurVeil drug-coated balloon

November 7, 2018 By Sarah Faulkner Leave a Comment

Surmodics (NSDQ:SRDX) touted data this week from an early feasibility study of the company’s SurVeil drug-coated balloon in patients with symptomatic peripheral artery disease due to de novo lesions of the femoral and popliteal arteries. All of the study’s 13 subjects met the acute success measures of safety at 12 months, Surmodics reported, and no […]

Filed Under: Clinical Trials, Drug-Device Combinations, Vascular Tagged With: SurModics Inc.

Surmodics reports positive one-year data for SurVeil drug-coated balloon

November 7, 2018 By Sarah Faulkner Leave a Comment

Surmodics (NSDQ:SRDX) touted data this week from an early feasibility study of the company’s SurVeil drug-coated balloon in patients with symptomatic peripheral artery disease due to de novo lesions of the femoral and popliteal arteries. All of the study’s 13 subjects met the acute success measures of safety at 12 months, Surmodics reported, and no participants […]

Filed Under: Clinical Trials, Drug-Device Combinations, Pharmaceuticals, Wall Street Beat Tagged With: SurModics Inc.

CardioMech taps medtech vet Nehm for CEO | Personnel Moves, November 5, 2018

November 5, 2018 By Brad Perriello Leave a Comment

 CardioMech taps medtech veteran Nehm for CEO Swedish mitral valve repair company CardioMech said today that it named medical device industry veteran Richard Nehm as president & CEO effective immediately. Nehm’s resume includes stints at Boston Scientific (NYSE:BSX), Abbott (NYSE:ABT) acquisition Tendyne and ATS Medical (acquired by Medtronic (NYSE:MDT)). CardioMech also named Spinal Stabilization Technologies president […]

Filed Under: Business/Financial News Tagged With: Cantel Medical Corp., CardioMech, Eos Imaging, intersectent, Medibio, micronsolutions, Personnel Moves, Restoration Robotics Inc., Stereotaxis, SurModics Inc., Vascular Insights

Surmodics’ acquisition hits earnings bottom line

August 7, 2018 By Nancy Crotti Leave a Comment

Surmodics (NSDQ:SRDX) today posted earnings that beat expectations on Wall Street and adjusted its guidance for the remaining year. The Eden Prairie, Minn. company took an expected hit to earnings due to its $5 million-plus acquisition of Embolitech’s thrombectomy platform. Surmodics posted a net loss of -$2.68 million compared with a profit of $720 million in the […]

Filed Under: Blog, Business/Financial News, News Well, Vascular Tagged With: embolitech, SurModics Inc.

SurModics acquires Embolitech thrombectomy tech for $5m

May 14, 2018 By Fink Densford Leave a Comment

SurModics (NSDQ:SRDX) said today it inked a deal with Embolitech to acquire its thrombectomy platform and the associated intellectual property in a deal worth $5 million up front, with additional payments based on regulatory milestones. The newly acquired tech platform is designed for use in the peripheral vasculature to remove hard blood clots, Eden Prairie, Minn.-based SurModics […]

Filed Under: Business/Financial News, Catheters, Mergers & Acquisitions, Vascular Tagged With: SurModics Inc.

SurModics wins FDA nod for low-profile PTA balloon dilation catheter

April 24, 2018 By Fink Densford Leave a Comment

SurModics (NSDQ:SRDX) said yesterday it won FDA 510(k) clearance for its .018″ low-profile percutaneous transluminal angioplasty balloon dilation catheter designed for peripheral vascular use. The newly cleared low-profile catheter features the Eden Prairie, Minn.-based company’s low-friction, low-particulate Serene hydrophilic coating with a range of between 2mm to 10mm. “We are delighted to announce this latest of three […]

Filed Under: 510(k), Catheters, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: SurModics Inc.

Abbott, Surmodics ink $25m deal for drug-coated balloon tech

February 27, 2018 By Sarah Faulkner Leave a Comment

Abbott (NYSE:ABT) is slated to pay $25 million upfront for the global commercialization rights to Surmodics‘ (NSDQ:SRDX) SurVeil drug-coated balloon, the companies announced today. The company’s drug-device combo, which is in pivotal trials in the U.S., is designed to treat peripheral artery disease in the superficial femoral artery. According to the deal, Abbott could also negotiate agreements […]

Filed Under: Drug-Device Combinations, Pharmaceuticals, Vascular, Wall Street Beat Tagged With: Abbott, SurModics Inc.

Surmodics misses sales estimates in Q1

February 8, 2018 By Sarah Faulkner Leave a Comment

Shares in Surmodics (NSDQ:SRDX) fell slightly today after the medical device maker missed expectations on Wall Street with its first quarter results. The Eden Prairie, Minn.-based company swung to a net loss of -$1.5 million on sales of $17.0 million for the 3 months ended Dec. 31, for a sales loss of -4% compared with the same […]

Filed Under: Drug-Device Combinations, MassDevice Earnings Roundup, Pharmaceuticals, Vascular, Wall Street Beat Tagged With: SurModics Inc.

SurModics wins FDA nod for Telemark crossing microcatheter

January 22, 2018 By Brad Perriello Leave a Comment

SurModics (NSDQ:SRDX) said today that it won 510(k) clearance from the FDA for its Telemark 0.014″ coronary and peripheral microcatheter, saying it plans to have the device on the U.S. market “in the coming months.” The Eden Prairie, Minn.-based medical device company said Telemark combines its Xtreme composite shaft technology with its Pristyne hydrophilic coating and […]

Filed Under: Catheters, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: peripheral, SurModics Inc.

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS